You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CART therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumors of Digestive Organs Trial in Hangzhou (gucy2c cart cells)

Recruiting
  • Malignant Neoplasms of Digestive Organs
  • gucy2c cart cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Feb 26, 2022

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

Recruiting
  • Multiple Myeloma
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023

CART Therapy Trial in Madrid

Completed
  • CART Therapy
    • Madrid, Spain
      Angel Cedillo
    May 26, 2022

    Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

    Completed
    • Leukemia
    • +4 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jan 19, 2023

      Multiple Myeloma Trial in Philadelphia (BCMA CART + huCART19, CART BCMA or CART BCMA + huCART19, Single-dose infusion of CART

      Active, not recruiting
      • Multiple Myeloma
      • BCMA CART + huCART19
      • +2 more
      • Philadelphia, Pennsylvania
        Univ. of Pennsylvania
      Jul 11, 2022

      Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)

      Not yet recruiting
      • Refractory HIV Associated Kaposi Sarcoma
      • Dostarlimab in Combination Antiretroviral Therapy
      • (no location specified)
      Dec 2, 2022

      Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

      Not yet recruiting
      • Kidney Transplant
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Sep 20, 2023

      Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy Trial (ultra-fraction radiotherapy)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • ultra-fraction radiotherapy
      • (no location specified)
      Aug 22, 2022

      B-cell Acute Lymphoblastic Leukemia, B Lineage Lymphoblastic Lymphoma Trial in Philadelphia (Autologous, humanized anti-CD22 CAR

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • B Lineage Lymphoblastic Lymphoma
      • Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
      • Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Jan 25, 2023

      Malignant Tumors of Digestive Organs Trial in Hefei (gucy2c cart cells)

      Not yet recruiting
      • Malignant Neoplasms of Digestive Organs
      • gucy2c cart cells
      • Hefei, Anhui, China
        Anhui provincial cancer hospital
      Feb 28, 2021

      HIV-infected Patients Switching to Long Acting Dual Therapy

      Not yet recruiting
      • HIV-1-infection
        • (no location specified)
        Jun 24, 2022

        SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy

        Recruiting
        • Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
        • COVID-19 serology IgG
        • Detroit, Michigan
          Henry Ford Health System
        Jul 19, 2022

        Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

        Not yet recruiting
        • Leukemia, Acute Lymphoblastic
        • Lymphoma, Non-Hodgkin
        • CART-19
        • Ribeirao Preto, Sao Paulo, Brazil
          Ribeirao Preto School of Medicine, University of Sao Paulo
        Oct 23, 2023

        Therapy Related Leukemia Trial in Guangdong (Sequential Treatment With different CART)

        Recruiting
        • Therapy Related Leukemia
        • Sequential Treatment With different CART
        • Guangdong, Guangdong, China
          Southern Medical University Zhujiang Hospital
        Aug 9, 2021

        Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome Trial in Mexico city (Valganciclovir,

        Completed
        Has Results
        • Kaposi Sarcoma
        • +2 more
        • Mexico city, Mexico
          Instituto Nacional de Cancerologia
        Nov 23, 2021

        Relapsed/Refractory Multiple Myeloma(MM) Trial in Guangdong (CART therapy in Relapsed/Refractory multiple myeloma)

        Terminated
        • Relapsed/Refractory Multiple Myeloma(MM)
        • CART therapy in Relapsed/Refractory multiple myeloma
        • Guangdong, Guangdong, China
          Southern Medical University Zhujiang Hospital
        Sep 17, 2021

        Relapsed/Refractory Acute Myeloid Leukemia(AML) Trial in Guangdong (CART therapy in Acute myeloid leukemia(AML))

        Terminated
        • Relapsed/Refractory Acute Myeloid Leukemia(AML)
        • CART therapy in Acute myeloid leukemia(AML)
        • Guangdong, Guangdong, China
          Southern Medical University Zhujiang Hospital
        Sep 5, 2021

        HIV/AIDS, ANTIRETROVIRAL TREATMENT Trial in Mexico (iART, cART)

        Recruiting
        • HIV/AIDS
        • ANTIRETROVIRAL TREATMENT
        • iART
        • cART
        • Mexico, Mexico
          Centro de Investigacion en Enfermedades Infecciosas
        Feb 15, 2022

        Ovarian Cancer Trial in Shanghai (anti- MESO CAR-T cells, Fludarabine, Cyclophosphamide)

        Recruiting
        • Ovarian Cancer
        • anti- MESO CAR-T cells
        • +2 more
        • Shanghai, Shanghai, China
          Shanghai 6th People's Hospital
        Aug 9, 2021

        Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Chapel Hill, Houston (CAR.CD30 T cells)

        Active, not recruiting
        • Non-Hodgkin's Lymphoma
        • Hodgkin's Lymphoma
        • CAR.CD30 T cells
        • Chapel Hill, North Carolina
        • +2 more
        Mar 16, 2022

        Multiple Myeloma Trial in United States (Talquetamab)

        Recruiting
        • Multiple Myeloma
        • Basking Ridge, New Jersey
        • +6 more
        Sep 27, 2023

        Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Suzhou (CD19/22 CART, Tislelizumab)

        Unknown status
        • Relapsed Non Hodgkin Lymphoma
        • Refractory Non-Hodgkin Lymphoma
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Jul 30, 2021

        ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell

        Recruiting
        • Relapsed Non Hodgkin Lymphoma
        • Refractory Non-Hodgkin Lymphoma
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Soochow University
          Jun 7, 2021

          Leukemia, T Cell Trial in Beijing (CD7 CART)

          Recruiting
          • Leukemia, T Cell
          • CD7 CART
          • Beijing, Hebei, China
            He bei Yan da Lu dao pei Hospital
          May 24, 2022

          Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

          Recruiting
          • Recurrent Neuroblastoma
          • +3 more
          • Palo Alto, California
          • +3 more
          Jan 25, 2023